Bausch + Lomb announced the U.S. FDA has approved the TENEO Excimer Laser Platform for laser-assisted in situ keratomileusis vision correction surgery for myopia and myopic astigmatism.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on BLCO:
